查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1320229

奈米醫藥市場:各適應症，各分子類型，各用途，各國，各地區- 產業分析，市場規模，市場佔有率，2023-2030年 預測

Nanomedicine Market with COVID-19 Impact Analysis, By Indication, By Molecule Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 364 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022年奈米藥物市場規模為1809.056億美元，2023年至2030年複合年增長率為10.9%

奈米醫學市場 - 市場動態：

藥物傳輸技術的進步和醫療設施投資的增加預計將推動市場需求

奈米技術將藥物精確地輸送到需要的地方，從而提高治療效果。奈米顆粒藥物傳輸系統、奈米膠囊和奈米級藥物載體是正在研究的技術之一，旨在提高藥物傳輸的精確度、控制和安全性。隨著世界各國政府和商業組織增加對醫療基礎設施的投資，奈米醫學等先進治療技術正變得越來越普遍。經合組織的最新估計顯示，在政府和強制性計劃的推動下，2020 年衛生支出平均增長5%，以滿足應對COVID-19 大流行的額外需求。這是由支出異常高的增長（增長8.1 %）推動的。 ）。奈米技術的最新發展為新的奈米醫學應用的發展提供了巨大的機會。持續的研究和發展促使疾病治療和預防的進步。然而，開發和生產醫用奈米顆粒的成本很高。這些高成本會降低奈米醫學產品的可用性，特別是在發展中國家和貧困地區。

奈米醫學市場 - 主要見解：

  • 由於人們對永續成長的認識不斷增強，奈米醫學產業預計將以顯著的速度成長
  • 根據適應症區隔，預計臨床腫瘤學將在 2022 年佔最大的市場佔有率。
  • 從分子類型來看，2022年奈米粒子將是主要類型。
  • 從應用來看，2022年藥物傳遞是主要類型。
  • 按地區劃分，北美將在 2022 年實現銷售領先。

奈米醫學市場 - 區隔分析：

全球奈米醫學市場根據適應症、分子類型、應用和區域進行區隔。

市場依適應症分為三類：臨床腫瘤學、傳染病、臨床心臟、骨科和其他。臨床腫瘤學預計將主導市場成長。臨床腫瘤學、研究和癌症治療是奈米醫學產生重大影響的關鍵領域。

市場依分子類型分為四大類：奈米顆粒、奈米殼、奈米管、奈米裝置。奈米顆粒在市場上佔主導地位，並可能在預測期內保持其主導地位。作為利用奈米粒子預防和治療疾病的醫學分支，奈米醫學在改變醫療保健方面展現了巨大的潛力。

市場依應用分為四類：治療、體外診斷、藥物傳遞、體內影像及植入。藥物傳輸領域佔市場主導地位。奈米醫學在藥物傳遞的應用是醫學中最有前途的領域之一。

奈米醫學市場 - 地理洞察：

從地區來看，該市場遍佈北美、拉丁美洲、歐洲、亞太地區以及中東和非洲地區。這些地區根據其開展業務的國家進一步劃分。預計北美將主導奈米醫學市場的成長。人們越來越認識到奈米技術在醫療保健方面的好處、慢性病和危及生命的疾病的擴散以及人口老化正在推動北美對奈米醫學的需求。據美國疾病管制與預防中心 (CDC) 稱，美國每年 3.8 兆美元的醫療保健支出中有 90% 用於患有慢性病和精神健康問題的人。根據最近發布的《對抗慢性病夥伴關係》報告，到2030 年，治療七種最常見的慢性病，??再加上生產力損失，將給美國經濟造成每年2 兆美元的損失，即每人8,600 美元。由於擁有先進的醫療設施和訓練有素的醫療專業人員、強大的研發活動以及主要參與者的存在，預計歐洲和亞太地區將在預測期內主導市場，預計將推動成長。

奈米醫學市場競爭格局：

奈米醫學市場是一個快速成長的新興市場，由於慢性病的流行、人口老化和技術進步，全球需求不斷增加。公司正大力投資研發，以開發創新的奈米醫學解決方案。競爭優勢是基於技術創新和開發產品的功效。許多公司結盟和合作，以降低研發成本並推動產品開發和批准。這些合作通常涉及專業知識和資源的交流，幫助公司獲得競爭優勢。例如，2022年10月21日，GE醫療集團與Accuray Incorporated宣佈建立全球合作夥伴關係，共同開發解決方案，使世界各地更多的醫療團隊能夠在治療過程中的任何時刻調整患者護理，並宣布達成商業合作夥伴協議。兩家公司將共同提供全面的產品，將GE Healthcare 的精準診斷工具與Accuray Incorporated 的創新放射治療交付能力相結合，推動放射治療實踐的發展，幫助癌症患者接受個人化治療。使患者能夠接受標準化治療。

目錄

第1章 奈米醫藥市場概要

  • 調查範圍
  • 市場估計年數

第2章 摘要整理

  • 市場明細
  • 競爭考察

第3章 奈米醫藥的主要市場趨勢

  • 奈米醫藥推動市場要素
  • 奈米醫藥阻礙市場要素
  • 奈米醫藥市場機會
  • 奈米醫藥市場今後趨勢

第4章 奈米醫藥產業的調查

  • PEST分析
  • 波特的五力分析
  • 成長預測的製圖
  • 法規結構的分析

第5章 奈米醫藥市場:COVID-19影響分析

  • COVID-19前的影響分析
  • COVID-19後的影響分析

第6章 奈米醫藥市場形勢

  • 奈米醫藥市場佔有率分析，2022年
  • 各主要製造商的明細資料
    • 現有企業的分析
    • 新興企業的分析

第7章 奈米醫藥市場- 各適應症

  • 概要
    • 各適應症的市場區隔佔有率分析
    • 臨床腫瘤
    • 感染疾病
    • 臨床心臟
    • 整形外科
    • 其他

第8章 奈米醫藥市場- 各分子類型

  • 概要
    • 各分子類型的市場區隔佔有率分析
    • 奈米粒子
      • 金屬·金屬氧化物奈米粒子
      • 微脂體
      • 聚合物·聚合物藥物複合體
      • 水凝膠奈米粒子
      • 樹狀聚合物
      • 無機奈米粒子
    • 奈米貝殼
    • 奈米碳管
    • 奈米設備

第9章 奈米醫藥市場- 各用途

  • 概要
    • 各用途的市場區隔佔有率分析
    • 治療
    • 體外診斷
    • 藥物輸送
    • 生物內成像
    • 植入

第10章 奈米醫藥市場-各地區

  • 簡介
  • 北美
    • 概要
    • 主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概要
    • 主要製造商
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 其他
  • 亞太地區(APAC)
    • 概要
    • 主要製造商
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 其他
  • 南美
    • 概要
    • 主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲
    • 概要
    • 主要製造商
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第11章 主要供應商分析- 奈米醫藥產業

  • 競爭儀表板
  • 企業簡介
    • Abbott Laboratories
    • CombiMatrix Corporation
    • Celgene Corporation
    • Nanospectra Biosciences, Inc.
    • GE Healthcare
    • Johnson &Johnson Services, Inc.
    • Mallinckrodt Pharmaceuticals
    • Merck &Co., Inc.
    • Pfizer, Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Arrowhead Pharmaceuticals, Inc.

第12章 分析師的全方位展望

Product Code: ANV1540

REPORT HIGHLIGHT

Nanomedicine Market size was valued at USD 180,905.6 Million in 2022, expanding at a CAGR of 10.9% from 2023 to 2030.

Nanomedicine is the application of nanotechnology to achieve innovation in healthcare. It uses the properties developed by a material at its nonmetric scale 10-9 m which often differ in terms of physics, chemistry, or biology from the same material at a bigger scale. Nanomedicine offers the potential to provide early detection and prevention, as well as significantly enhance diagnosis, therapy, and follow-up for a wide range of diseases, including cancer. Overall, numerous Nanomedicine items are currently in clinical trials, spanning all main disorders such as cardiovascular, neurological, musculoskeletal, and inflammatory. Nanomedicine, which enables advancements in all sectors of healthcare, now accounts for over 80 marketed items, ranging from nano-delivery and pharmaceutical to medical imaging, diagnostics, and biomaterials.

Nanomedicine Market- Market Dynamics:

Rising advancing technologies for drug delivery and Growing investment in healthcare facilities are expected to propel market demand

Nanotechnology provides medications to be delivered to the exact recognition where they are needed, increasing therapy effectiveness. Nanoparticle drug delivery systems, nano-encapsulation, and nanoscale drug carriers are among the technologies being researched to improve the precision, control, and safety of drug delivery. As governments and commercial entities around the world boost their investment in healthcare infrastructure, sophisticated treatment techniques such as Nanomedicine are becoming more popular. Latest OECD estimates point to average health expenditure growth of 5% in 2020, driven by the exceptionally high growth in spending by government and compulsory schemes (+8.1%) in response to the additional need to address the COVID-19 pandemic. Recent developments in nanotechnology provide enormous opportunities for the development of new Nanomedicine applications. Continuous research and development can result in advancements in illness treatment and prevention. However, the development and production of nanoparticles for medical use can be expensive. These high costs can make Nanomedicine products less accessible, especially in developing and underprivileged regions.

Nanomedicine Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Nanomedicine market is estimated to grow annually at a CAGR of around 10.9% over the forecast period (2023-2030)
  • The Nanomedicine industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
  • Based on Indication segmentation, Clinical Oncology was predicted to show maximum market share in the year 2022
  • Based on Molecular type segmentation, Nanoparticles were the leading type in 2022
  • Based on Application segmentation, drug delivery was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Nanomedicine Market- Segmentation Analysis:

The Global Nanomedicine Market is segmented on the basis of Indication, Molecular type Application, and Region.

The market is divided into three categories based on Indication: Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, and Others. Clinical Oncology is expected to dominate the market growth. Clinical oncology, the research, and cancer treatment is one of the key sectors where Nanomedicine has a substantial influence.

The market is divided into four categories based on Molecule Type: Nanoparticles, Nanoshells, Nanotubes, and Nanodevices. Nanoparticles dominate the market and are likely to maintain their dominance during the forecast period. As a subfield of medicine that uses nanoparticles to prevent and treat diseases, Nanomedicine has been showing remarkable potential for transforming healthcare.

The market is divided into four categories based on Application: Therapeutics, In-vitro Diagnostics, Drug Delivery, In-vivo Imaging, and Implants. The drug delivery segment dominates the market. The application of Nanomedicine in drug delivery is one of the most promising areas of healthcare.

Nanomedicine Market- Geographical Insights:

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the Nanomedicine Market. Growing awareness of the prospective benefits of nanotechnology in healthcare, a surge in chronic and life-threatening diseases, and a population that is aging are all fueling up demand for Nanomedicine in North America. According to the CDC, 90% of the nation's USD3.8 trillion per year healthcare costs can be attributed to people with chronic diseases and mental health conditions. A recent Partnership to Fight Chronic Disease publication determined that treatment of the seven most common chronic diseases, coupled with productivity losses, will cost the U.S. economy USD2 trillion dollars annually USD8,600 per person, by 2030. Europe and Asia Pacific region are expected to drive market growth in the forecast period, due to the availability of advanced healthcare facilities with trained medical professionals, a rise in the number of R&D activities along with the large presence of key players.

Nanomedicine Market- Competitive Landscape:

The Nanomedicine Market is a rapidly growing emerging area with rising demand worldwide driven by the increasing prevalence of chronic diseases, aging populations, and technological improvements. Companies are heavily investing in R&D in order to develop revolutionary Nanomedicine solutions. The competitive advantage is based on technological innovation and the efficacy of developed items. Many companies are entering into partnerships and collaborations to reduce R&D expenses and advance product development and approval. These collaborations frequently involve the exchange of expertise and resources, which can help businesses obtain a competitive advantage. For example, on 21 Oct, 2022, GE Healthcare and Accuray Incorporated announced nowadays global commercial collaboration agreement to develop solutions that will allow more healthcare teams across the world to adapt patients' care at every point of their treatment path. The two companies will make available a comprehensive offering that combines GE Healthcare's precision diagnostic tools and Accuray Incorporated's innovative radiation therapy delivery capabilities to advance radiation therapy practice and help patients diagnosed with cancer gain personalized care.

Recent Developments:

On 9 January 2023, A novel combination of artificial intelligence and production techniques could change the future of Nanomedicine, according to Cornell researchers using a new USD3 million grant from the National Science Foundation to revolutionize how polymer nanoparticles are manufactured.

Key features of the study:

  • This proposed research study on Nanomedicine market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Nanomedicine market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Nanomedicine market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Nanomedicine market
  • Impact of COVID-19 on Nanomedicine market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Nanomedicine market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Nanomedicine market, we have also included competitive landscape and key innovator analysis for the Nanomedicine market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Nanomedicine market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Nanomedicine market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NANOMEDICINE MARKET KEY PLAYERS

  • Abbott Laboratories
  • CombiMatrix Corporation
  • Celgene Corporation
  • Nanospectra Biosciences, Inc.
  • GE Healthcare
  • Johnson & Johnson Services, Inc.
  • Mallinckrodt Pharmaceuticals
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Arrowhead Pharmaceuticals, Inc.

GLOBAL NANOMEDICINE MARKET, BY INDICATION

  • Clinical Oncology
  • Infectious Diseases
  • Clinical Cardiology
  • Orthopedics
  • Others

GLOBAL NANOMEDICINE MARKET, BY MOLECULE TYPE

  • Nanoparticles
  • Metal & Metal Oxide Nanoparticles
  • Liposomes
  • Polymers & Polymer Drug Conjugates
  • Hydrogel Nanoparticles
  • Dendrimers
  • Inorganic Nanoparticles
  • Nanoshells
  • Nanotubes
  • Nanodevices

GLOBAL NANOMEDICINE MARKET, BY APPLICATION

  • Therapeutics
  • In-vitro Diagnostics
  • Drug Delivery
  • In-vivo Imaging
  • Implants

GLOBAL NANOMEDICINE MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Nanomedicine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Nanomedicine Market Snippet by Indication
    • 2.1.2. Nanomedicine Market Snippet by Molecule Type
    • 2.1.3. Nanomedicine Market Snippet by Application
    • 2.1.4. Nanomedicine Market Snippet by Country
    • 2.1.5. Nanomedicine Market Snippet by Region
  • 2.2. Competitive Insights

3. Nanomedicine Key Market Trends

  • 3.1. Nanomedicine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Nanomedicine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Nanomedicine Market Opportunities
  • 3.4. Nanomedicine Market Future Trends

4. Nanomedicine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Nanomedicine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Nanomedicine Market Landscape

  • 6.1. Nanomedicine Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Nanomedicine Market - By Indication

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
    • 7.1.2. Clinical Oncology
    • 7.1.3. Infectious Diseases
    • 7.1.4. Clinical Cardiology
    • 7.1.5. Orthopedics
    • 7.1.6. Others

8. Nanomedicine Market - By Molecule Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Molecule Type, 2022 & 2030 (%)
    • 8.1.2. Nanoparticles
      • 8.1.2.1. Metal & Metal Oxide Nanoparticles
      • 8.1.2.2. Liposomes
      • 8.1.2.3. Polymers & Polymer Drug Conjugates
      • 8.1.2.4. Hydrogel Nanoparticles
      • 8.1.2.5. Dendrimers
      • 8.1.2.6. Inorganic Nanoparticles
    • 8.1.3. Nanoshells
    • 8.1.4. Nanotubes
    • 8.1.5. Nanodevices

9. Nanomedicine Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 9.1.2. Therapeutics
    • 9.1.3. In-vitro Diagnostics
    • 9.1.4. Drug Delivery
    • 9.1.5. In-vivo Imaging
    • 9.1.6. Implants

10. Nanomedicine Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Nanomedicine Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Nanomedicine Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Nanomedicine Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Nanomedicine Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Nanomedicine Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Nanomedicine Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Abbott Laboratories
    • 11.2.2. CombiMatrix Corporation
    • 11.2.3. Celgene Corporation
    • 11.2.4. Nanospectra Biosciences, Inc.
    • 11.2.5. GE Healthcare
    • 11.2.6. Johnson & Johnson Services, Inc.
    • 11.2.7. Mallinckrodt Pharmaceuticals
    • 11.2.8. Merck & Co., Inc.
    • 11.2.9. Pfizer, Inc.
    • 11.2.10. Teva Pharmaceutical Industries Ltd.
    • 11.2.11. Arrowhead Pharmaceuticals, Inc.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Nanomedicine Market: Indication Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Nanomedicine Market, by Indication 2018-2030 (USD Million)
  • TABLE Nanomedicine Market: Molecule Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Molecule Type
  • TABLE Global Nanomedicine Market, by Molecule Type 2018-2030 (USD Million)
  • TABLE Nanomedicine Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Nanomedicine Market, by Application 2018-2030 (USD Million)
  • TABLE Nanomedicine Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Nanomedicine Market, by Region 2018-2030 (USD Million)
  • TABLE North America Nanomedicine Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Nanomedicine Market, by Indication, 2018-2030 (USD Million)
  • TABLE North America Nanomedicine Market, by Molecule Type, 2018-2030 (USD Million)
  • TABLE North America Nanomedicine Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Nanomedicine Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Nanomedicine Market, by Indication, 2018-2030 (USD Million)
  • TABLE Europe Nanomedicine Market, by Molecule Type, 2018-2030 (USD Million)
  • TABLE Europe Nanomedicine Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Nanomedicine Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Nanomedicine Market, by Indication, 2018-2030 (USD Million)
  • TABLE Asia Pacific Nanomedicine Market, by Molecule Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Nanomedicine Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Nanomedicine Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Nanomedicine Market, by Indication, 2018-2030 (USD Million)
  • TABLE Latin America Nanomedicine Market, by Molecule Type, 2018-2030 (USD Million)
  • TABLE Latin America Nanomedicine Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Nanomedicine Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Nanomedicine Market, by Indication, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Nanomedicine Market, by Molecule Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Nanomedicine Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Nanomedicine Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Indication segment market share analysis, 2022 & 2030
  • FIGURE Indication segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Molecule Type segment market share analysis, 2022 & 2030
  • FIGURE Molecule Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Nanomedicine Market share and leading players, 2022
  • FIGURE Europe Nanomedicine Market share and leading players, 2022
  • FIGURE Asia Pacific Nanomedicine Market share and leading players, 2022
  • FIGURE Latin America Nanomedicine Market share and leading players, 2022
  • FIGURE Middle East and Africa Nanomedicine Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Nanomedicine Market share analysis by country, 2022
  • FIGURE Germany Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Nanomedicine Market share analysis by country, 2022
  • FIGURE India Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Nanomedicine Market share analysis by country, 2022
  • FIGURE Brazil Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Nanomedicine Market share analysis by country, 2022
  • FIGURE Saudi Arabia Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)